product name:
Levomecol
Release form Levomecol:
ointment for external approx .: tubes of 30 g, 40 g or 50 g
Description Levomecol:
Ointment for external use, white or white with a yellowish tinge 1 g
chloramphenicol 7.5 mg
dioxomethyltetrahydropyrimidine (methyluracil) 40 mg
Excipients : macrogol 1500 - 190.5 mg, macrogol 400 - 762 mg.
30 g - aluminum tubes (1) - cardboard packs.
40 g - aluminum tubes (1) - cardboard packs.
50 g - aluminum tubes (1) - cardboard packs.
30 g - polyethylene laminate tubes (1) - cardboard packs.
40 g - polyethylene laminate tubes (1) - cardboard packs.
50 g - polyethylene laminate tubes (1) - cardboard packs.
ATX codes
D06C (Antibiotics in combination with other antimicrobials)
Clinical and pharmacological groups / Group affiliation
Preparation with antibacterial and tissue regeneration improving action for external use
Active substance Levomecol:
chloramphenicol
dioxomethyltetrahydropyrimidine
Pharmaco-therapeutic group:
Antimicrobial combined agent
pharmachologic effect Levomecol:
Combined drug for topical use, has anti-inflammatory (dehydrating) and antimicrobial effects, is active against gram-positive and gram-negative microorganisms (staphylococci, Pseudomonas aeruginosa and Escherichia coli).
Easily penetrates deep into tissues without damaging biological membranes, stimulates regeneration processes.
In the presence of pus and necrotic masses, the antibacterial effect persists. Dioxomethyltetrahydropyrimidine, normalizing nucleic acid metabolism, stimulates the processes of regeneration in wounds, growth and granulation maturation of tissue, epithelization, and has an anti-inflammatory (dehydrating) effect.
Indications Levomecol:
Purulent wounds (including those infected with mixed microflora) in the first (purulent-necrotic) phase of the wound process.
Method of application, course and dosage Levomecol:
Locally. The drug is impregnated with sterile gauze napkins, which are loosely filled in the wound. It is possible to enter the purulent cavity through a catheter (drainage tube) with a syringe.
Application during pregnancy and lactation:
Application during pregnancy is possible if the benefit to the mother outweighs the risk to the fetus.
During lactation, you should either stop using the drug or breastfeeding.
Side effect Levomecol:
Allergic reactions: skin rashes.
Contraindications for use Levomecol:
Children under 1 year of age (in newborns, the biotransformation of chloramphenicol occurs more slowly than in adults); hypersensitivity to the components of the combination.
Carefully
Pregnancy, lactation (breastfeeding).
special instructions Levomecol:
When applied to large areas of the skin and long courses of treatment, it is necessary to carry out a clinical blood test.
Application in children
The use is contraindicated in children under 1 year of age (in newborns, the biotransformation of chloramphenicol occurs more slowly than in adults).
Nosology (ICD codes)
Indications:
Purulent wounds (including those infected with mixed microflora) in the first (purulent-necrotic) phase of the wound process.
Contraindications for use
Children under 1 year of age (in newborns, the biotransformation of chloramphenicol occurs more slowly than in adults); hypersensitivity to the components of the combination.
Carefully
Pregnancy, lactation (breastfeeding) Method of application, course and dosage Levomecol:
Locally. The drug is impregnated with sterile gauze napkins, which are loosely filled in the wound. It is possible to enter the purulent cavity through a catheter (drainage tube) with a syringe.
Marketing Authorization Holder
NIZHPHARM AO (Russia)
